Unknown

Dataset Information

0

Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.


ABSTRACT: BACKGROUND:Early risk stratification of patients with suspected acute myocardial infarction (AMI) constitutes an unmet need in current daily clinical practice. We aimed to evaluate the predictive value of soluble urokinase-type plasminogen activator receptor (suPAR) levels for 1-year mortality in patients with suspected AMI. METHODS AND RESULTS:suPAR levels were determined in 1314 patients presenting to the emergency department with suspected AMI. Patients were followed up for 12 months to assess all-cause mortality. Of 1314 patients included, 308 were diagnosed with AMI. Median suPAR levels did not differ between subjects with AMI compared to non-AMI (3.5 ng/ml vs. 3.2 ng/ml, p?=?0.066). suPAR levels reliably predicted all-cause mortality after 1 year. Hazard ratio for 1-year mortality was 12.6 (p?

SUBMITTER: Sorensen NA 

PROVIDER: S-EPMC6867986 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction.

Sörensen Nils A NA   Nikorowitsch Julius J   Neumann Johannes T JT   Rübsamen Nicole N   Goßling Alina A   Hartikainen Tau S TS   Blankenberg Stefan S   Westermann Dirk D   Zeller Tanja T   Karakas Mahir M  

Clinical research in cardiology : official journal of the German Cardiac Society 20190416 12


<h4>Background</h4>Early risk stratification of patients with suspected acute myocardial infarction (AMI) constitutes an unmet need in current daily clinical practice. We aimed to evaluate the predictive value of soluble urokinase-type plasminogen activator receptor (suPAR) levels for 1-year mortality in patients with suspected AMI.<h4>Methods and results</h4>suPAR levels were determined in 1314 patients presenting to the emergency department with suspected AMI. Patients were followed up for 12   ...[more]

Similar Datasets

| S-EPMC5704352 | biostudies-literature
| S-EPMC5963104 | biostudies-literature
| S-EPMC6468350 | biostudies-literature
| S-EPMC7408822 | biostudies-literature
| S-EPMC6669298 | biostudies-literature
| S-EPMC6127402 | biostudies-literature
| S-EPMC6614646 | biostudies-literature
| S-EPMC7074407 | biostudies-literature
| S-EPMC6715219 | biostudies-literature
| S-EPMC9683642 | biostudies-literature